The Dutch club have developed talents such as Koopmeiners, Reijnders, Pavlidis, Addai and Parrott thanks to a series of innovative techniques in their youth academy: from training players grouped by ...

Demonstrations that LTS-201 results in deep, dose-dependent MSH3 mRNA KD, ranging from 48% to 94%, in >90% of MSNs in nonhuman primates. Preclinical validation that LTS-201-mediated MSH3 KD results in ...

OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios. Why it matters: Rival AI ...

Reflector Bio, founded by MIT-trained computational biologist and early employee at Flagship Pioneering's Cellarity, Yuge Ji, ...

By incorporating BIO-key's identity security technologies into its cybersecurity portfolio, Cipher will be able to extend its offering beyond traditional cybersecurity protection to address one of the ...

SAN FRANCISCO, Nov. 3, 2026 /PRNewswire/ -- Differentia Bio, a developer of AI-powered human disease digital twins, today announced that therapeutic mechanisms identified by its disease modeling ...

A simulation study reports that a bio-inspired, AI-enabled wireless sensor network design improved network lifetime, energy ...

OpenAI has acquired Orchestra Bio, a company building software to coordinate complex drug development work. The deal, ...

A practical framework for partners across product supply, branding and professional installation. CALIFORNIA, CA, ...

OpenAI has acquired Orchestra Bio, a company whose platform coordinates drug development work across biopharma teams, and is bringing the startup's team and technology together with Rosalind, its AI ...

BIO-key International (NASDAQ:SKYI) was indicated down 6.49% premarket on October 26, 2026 from a Friday close of USD 3.39, ...

Researchers show that lexical and embedding-based drift measures between synthetic and real clinical text moderately predict ...